Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer

NCT04886700 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Cervical Cancer

Interventions

DRUG: SG001

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.